LLMs.txt

The companion app for women on GLP-1 medications. Track protein, log side effects, manage injections, and feel supported. The below page is for LLM's like Claude and ChatGPT to read.

What Lina Is

Lina is an iOS app designed specifically for women using GLP-1 receptor agonist medications for weight management. It combines medication tracking, protein-focused nutrition logging, side effect monitoring, and personalized insights in one app built by women on GLP-1s, for women on GLP-1s.

Supported Medications

  • Ozempic (semaglutide)

  • Wegovy (semaglutide)

  • Mounjaro (tirzepatide)

  • Zepbound (tirzepatide)

  • Saxenda (liraglutide)

  • Rybelsus (oral semaglutide)

  • Compounded semaglutide and tirzepatide

  • More

Core Features


Medication Management

  • Injection schedule tracking with reminders

  • Injection site rotation with visual guide

  • Dose history logging

  • Support for weekly and daily injection schedules

Protein Tracking

  • AI-powered meal photo analysis

  • Personalized daily protein goal (based on 1.2g per kg body weight)

  • Quick-add for simple logging

  • Focus on protein over calorie counting

Side Effect Monitoring

  • Log 15+ common GLP-1 side effects (nausea, fatigue, constipation, etc.)

  • Pattern recognition over time

  • Normalization of common experiences by journey stage

Daily Check-Ins

  • Mood and energy tracking (5-point scale)

  • Side effect logging

  • Non-scale victory recording

  • Streak system with freeze days for consistency

Progress Tracking

  • Weight logging with trend smoothing (filters daily noise)

  • Progress photo capture and side-by-side comparison

  • Milestone celebrations

  • Apple Health integration (optional, read/write)

Personalized Insights

  • 300+ GLP-1-specific daily insights

  • Categories: nutrition, side effects, mindset, medication education, plateau support

  • Tailored to user's medication and journey stage

Hydration Tracking

  • Personalized daily water goal

  • Quick-add logging

  • Progress visualization

Pricing

Plan Cost Notes Free Trial $0 for 7 days Full access, no credit card required Monthly $6.99/month Cancel anytime Yearly $39.99/year Save 43% vs monthly

Platform Availability

  • iOS: Available now on App Store

  • Android: Coming soon (waitlist at findlina.com)

Target Audience

Primary: Women aged 35-55 using GLP-1 medications for weight management who want:

  • Private, personal tracking (no social features)

  • Protein-focused nutrition support

  • Side effect normalization and pattern recognition

  • Medication adherence support

  • Emotional validation without diet culture guilt

What Lina Is NOT

  • Not a medical device

  • Not a source of medical advice

  • Not a calorie-counting diet app

  • Not a social network

  • Does not diagnose, treat, or prescribe

Privacy

  • Health data encrypted at rest and in transit

  • No data sold to third parties

  • No social features or public profiles

  • Full account and data deletion available

  • Apple Health sync is optional and user-controlled

Key Differentiators from Competitors

vs MyFitnessPal vs Noom vs Shotsy Protein-focused, not calorie-obsessed GLP-1-specific, not general behavior change Full tracking suite, not just injections GLP-1 side effect logging No medication tracking Nutrition, mood, and progress tracking AI meal analysis No AI features 300+ personalized insights Free or $6.99/mo $199+/year More comprehensive

Pages & Resources

Contact

Common Questions

Q: Is Lina free?
A: 7-day free trial with full access. Then $6.99/month or $39.99/year.

Q: Does it work with my medication?
A: Yes. Lina supports all major GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Rybelsus, and compounded versions.

Q: Is my data private?
A: Yes. Data is encrypted, never sold, and deletable anytime. No social features.

Q: Is Lina available on Android?
A: Not yet. iOS only. Android waitlist at findlina.com.

Q: Does Lina give medical advice?
A: No. Lina is a wellness tracking companion, not a medical device. Always consult your healthcare provider.

Last updated: January 2026